NASDAQ:MIRA MIRA Pharmaceuticals (MIRA) Stock Forecast, Price & News $4.49 +0.08 (+1.81%) (As of 09/25/2023 ET) Add Share Share Today's Range$4.42▼$5.2150-Day Range N/A52-Week Range$3.00▼$7.98Volume66,807 shsAverage Volume137,581 shsMarket Capitalization$66.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInsider TradesHeadlinesSEC FilingsSocial MediaProfileChartCompetitorsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media About MIRA PharmaceuticalsMIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.Read More MIRA Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MIRA Stock News HeadlinesAugust 25, 2023 | benzinga.comGeorge Cappy Mira Pharmaceuticals, IncAugust 14, 2023 | finance.yahoo.comMIRA Pharmaceuticals debuts on the Nasdaq with plans to revolutionize medicinal CBD and THCSeptember 26, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.August 14, 2023 | finance.yahoo.comMIRA Pharmaceuticals, Inc. Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day PodcastSee More Headlines Receive MIRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address MIRA Company Calendar Today9/25/2023Next Earnings (Estimated)12/15/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:MIRA CUSIPN/A CIK1904286 Webmirapharmaceuticals.com Phone737-289-0835FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares14,780,000Free FloatN/AMarket Cap$66.36 million OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Adam Kaplin M.D. (Age 56)Ph.D., Co-Founder, Pres & Chief Science Officer Comp: $50kDr. Christopher C. Chapman Jr. (Age 70)M.D., Exec. Chairman Mr. Erez Aminov (Age 45)CEO & Director Ms. Michelle Yanez M.B.A. (Age 51)CFO, Sec. & Treasurer Mr. Christos Nicholoudis Esq. (Age 33)Gen. Counsel & Director InsidersGeorge CappyBought 119,048 shares on 8/7/2023Total: $833,336.00 ($7.00/share)George CappyBought 157,170 shares on 8/2/2023Total: $1.10 M ($7.00/share)View All Insider Transactions MIRA Stock - Frequently Asked Questions How have MIRA shares performed in 2023? MIRA Pharmaceuticals' stock was trading at $6.01 at the beginning of 2023. Since then, MIRA stock has decreased by 25.3% and is now trading at $4.49. View the best growth stocks for 2023 here. When is MIRA Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, December 15th 2023. View our MIRA earnings forecast. When did MIRA Pharmaceuticals IPO? (MIRA) raised $9 million in an initial public offering (IPO) on Thursday, August 3rd 2023. The company issued 1,275,000 shares at a price of $7.00 per share. What is MIRA Pharmaceuticals' stock symbol? MIRA Pharmaceuticals trades on the NASDAQ under the ticker symbol "MIRA." When did the company's quiet period expire? MIRA Pharmaceuticals' quiet period expired on Tuesday, September 12th. MIRA Pharmaceuticals had issued 1,275,000 shares in its IPO on August 3rd. The total size of the offering was $8,925,000 based on an initial share price of $7.00. During the company's quiet period, insiders and any underwriters that worked on the IPO were prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company. How do I buy shares of MIRA Pharmaceuticals? Shares of MIRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is MIRA Pharmaceuticals' stock price today? One share of MIRA stock can currently be purchased for approximately $4.49. How much money does MIRA Pharmaceuticals make? MIRA Pharmaceuticals (NASDAQ:MIRA) has a market capitalization of $66.36 million. How can I contact MIRA Pharmaceuticals? The official website for the company is mirapharmaceuticals.com. The company can be reached via phone at 737-289-0835. This page (NASDAQ:MIRA) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.